Highlights Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 12/12/2025 GMT			5-day change	1st Jan Change
321.15 ^DKK	+0.45%		+3.73%	-48.55%

12-12	Sector Update: Health Care Stocks Advance Late Afternoon	MT
12-12	Sector Update: Health Care Stocks Edge Higher Friday Afternoon	MT

Highlights

EU Panel Backs Higher Dose of Novo Nordisk's Weight-loss Drug Wegovy	12-12	MT
Novo Nordisk A/S Announces More Efficacious Dose of Wegovy®? Recommends by the European Medicines Agency	12-12	CI
Eli Lilly Could Get FDA Decision for Weight-Loss Pill Orforglipron by March 2026	12-12	MT
Weight-loss drug developers line up to tap lucrative market as competition heats up	12-12	RE
Lexicon Pharmaceuticals, Inc. Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Ayl-Coa Synthetase 5 Reinforcing the Scientific Rationale for Lx9851	12-10	CI
Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial	12-10	RE
Novo Nordisk A/S (CPSE:NOVO B) completed the acquisition of Akero Therapeutics, Inc..	12-09	CI
Novo Nordisk Concludes Up to $5.2 Billion Takeover of Akero Therapeutics	12-09	MT
Novo Nordisk Completes Acquisition of Akero Therapeutics	12-09	FW
Novo Nordisk completes acquisition of Akero Therapeutics	12-09	RE
Pfizer partners with YaoPharma to develop weight management drug	12-09	RE
Weight-loss drugs fill a treatment gap for women with hormone disorder PCOS, doctors say	12-09	RE
Weight-loss drug developers line up to tap lucrative market as competition heats up	12-08	RE
Novo Nordisk Kept at Buy as Berenberg Notes Obesity Market Focus, FY26 Headwinds	12-08	MT
Novo Holdings Reportedly Plans to Sell 9.4 Million Shares in Evotec	12-07	CI
Sector Update: Health Care Stocks Lower Late Afternoon	12-05	MT
Sector Update: Health Care Stocks Decline Friday Afternoon	12-05	MT
European Equities Close Mixed in Friday Trading; EU GDP Grows 0.4% in Q3	12-05	MT
Sector Update: Health Care Stocks Rise Pre-Bell Friday	12-05	MT
Novo Nordisk Loses India Case to Halt Dr. Reddy's Production of Generic Semaglutide	12-05	MT
Novo Nordisk Presents New Topline Results from Their Evoke and Evoke+ Phase 3 Trials of Semaglutide	12-04	CI
Novo Nordisk Loses India Case to Halt Dr. Reddy's Production of Generic Semaglutide	12-04	MT
Germany's cartel office says it approved acquisition of Akero Therapeutics by Novo Nordisk	12-04	RE
Germany's cartel office says it approved acquisition of Akero Therapeutics by Novo Nordisk	12-04	RE
Akero Therapeutics stockholders approve acquisition by Novo Nordisk	12-03	RE